Category: Costing
-
The global Medical Tourism market, which includes fertility treatments and services, is set to experience significant growth, projected at a rate of 23% during the forecast period. This growth is driven by factors such as the demand for affordable healthcare, accessibility to advanced medical technologies, and the increasing popularity of specialized treatments and comprehensive service…
-
President Donald Trump announced two new policies aimed at improving access to in-vitro fertilization (IVF). The first policy is focused on lowering the cost of a key fertility drug. This is a significant development, as the high cost of fertility drugs is often a barrier to many people seeking IVF treatment. The second policy encourages…
-
President Donald Trump has announced a deal with drugmaker EMD Serono to reduce the cost of a common fertility medication, in an effort to make IVF treatment more affordable. The deal is part of Trump’s wider strategy to reduce the cost of in vitro fertilisation, following an executive order issued earlier this year. EMD Serono’s…
-
The article discusses President Trump’s efforts to lower the cost of In Vitro Fertilisation (IVF) through insurance guidance and drug agreements. The administration plans to issue guidance that would allow employers to offer IVF coverage as a benefit of company insurance plans. They also announced an agreement to reduce the cost of a popular fertility…
-
INVO Bioscience, a medical device company focused on creating simplified, lower-cost treatments for patients diagnosed with infertility, has amended its loan agreement with Decathlon Alpha V LP. The amendment is anticipated to provide the company with additional financial flexibility and capital to further its strategic growth initiatives. This report may be significant to those in…
-
A comprehensive market report on Uterine Fibroid Treatment Devices predicts a 7.0% growth from 2025 to 2033, fuelled by an increase in uterine fibroids in women of reproductive age, a rising demand for minimally invasive treatments, and heightened awareness of the complications fibroids can cause such as infertility, heavy bleeding, and pelvic pain. The report…
-
In a move that marks progress in reproductive justice and inclusivity, same-sex couples in the UK now have easier access to funded IVF treatments. This change in policy came as a response to the previously unfair system that required same-sex couples to undergo privately funded fertility treatments, often at high costs, before they could qualify…
-
A recent report from Capgemini and LIMRA, titled the ‘World Life Insurance Report 2026’, has found that individuals under 40 are increasingly skipping life insurance in favour of other benefits. The report suggested that the delay in traditional life milestones like marriage and parenthood is causing younger people to overlook life insurance. Instead, they are…
-
UK health leaders have called for a crackdown on unproven fertility treatments, which are offered by some clinics at high costs. The treatments, often marketed as ‘add-ons’, promise to boost the chances of having a baby but lack robust evidence to support these claims. The Human Fertilisation and Embryology Authority (HFEA) has highlighted 27 such…
-
The UK government has issued a stern warning to fertility clinics, urging them to stop offering ineffective and unproven treatments to couples trying to conceive. The Human Fertilisation and Embryology Authority (HFEA), UK’s fertility regulator, has raised concerns over the increasing number of fertility clinics that are promoting add-on treatments, which have no proven benefits,…